Favorable outcome of high-risk mediastnal diffuse large B-cell lymphoma(DLBCL) after dose-intensive chemoterapy, rituximab and autologous transplant(ASCT)

MUDr. Robert Pytlík Ph.D.

First Faculty of Medicine, Third Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, Central Library of Charles University, Faculty of Physical Education and Sport, Faculty of Science, Faculty of Mathematics and Physics

Favorable outcome of high-risk mediastnal diffuse large B-cell lymphoma(DLBCL) after dose-intensive chemoterapy, rituximab and autologous transplant(ASCT)

People